Preoperative Reduction in Smoking is Cost-Beneficial

-- Lisa Cockrell, PhD

Friday, February 6, 2009

FRIDAY, Feb. 6 (HealthDay News) -- Preoperative interventions for smoking cessation can result in modest cost savings, which may accumulate with the use of an institution-based smoking cessation program through reduced total hospitalization costs, according to research published in the February issue of Chest.

Gilles Hejblum, Ph.D., of INSERM in Paris, and colleagues used a cost-benefit analysis to simulate the implementation of a preoperative intervention for smoking cessation in patients who were smokers scheduled for hip or knee replacement surgery. The investigators used data from a prior randomized trial, which contained this patient population, as well as official French hospital costs for 2008.

The model showed that the use of a preoperative intervention for smoking cessation was associated with a cost savings of 117 euros per patient. This benefit was most dependent on the cost of the length of stay in the intensive care unit, the report indicates.

"Our study, based on the only available data compatible with a cost-benefit analysis, indicates that preoperative intervention for smoking cessation is highly beneficial for total hip and knee arthroplasty patients," the authors conclude. "The modest cost of such interventions is more than offset by short-term savings in hospitalization costs, owing to a reduction in postoperative complications."

Abstract
Full Text (subscription or payment may be required)

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Blogs

Survivorship: A Roadmap for Managing Fear [Webinar]
by OncoLink Editorial Team
March 04, 2014

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015